CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain

Lung cancer represents the leading cause of cancer-related mortality throughout the world. Patients die of local progression, disseminated disease, or both. At least one third of the people with lung cancer develop brain metastases at some point during their disease, even often before the diagnosis...

Full description

Bibliographic Details
Main Author: Sebastiano Cavallaro
Format: Article
Language:English
Published: MDPI AG 2013-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/14/1/1713
id doaj-2ce0475e166a49e6a121ac5937f0f206
record_format Article
spelling doaj-2ce0475e166a49e6a121ac5937f0f2062020-11-24T21:28:34ZengMDPI AGInternational Journal of Molecular Sciences1422-00672013-01-011411713172710.3390/ijms14011713CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the BrainSebastiano CavallaroLung cancer represents the leading cause of cancer-related mortality throughout the world. Patients die of local progression, disseminated disease, or both. At least one third of the people with lung cancer develop brain metastases at some point during their disease, even often before the diagnosis of lung cancer is made. The high rate of brain metastasis makes lung cancer the most common type of tumor to spread to the brain. It is critical to understand the biologic basis of brain metastases to develop novel diagnostic and therapeutic approaches. This review will focus on the emerging data supporting the involvement of the chemokine CXCL12 and its receptor CXCR4 in the brain metastatic evolution of non-small-cell lung cancer (NSCLC) and the pharmacological tools that may be used to interfere with this signaling axis.http://www.mdpi.com/1422-0067/14/1/1713brain metastaseschemokinesCXCL12CXCR4lung cancermetastasis
collection DOAJ
language English
format Article
sources DOAJ
author Sebastiano Cavallaro
spellingShingle Sebastiano Cavallaro
CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain
International Journal of Molecular Sciences
brain metastases
chemokines
CXCL12
CXCR4
lung cancer
metastasis
author_facet Sebastiano Cavallaro
author_sort Sebastiano Cavallaro
title CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain
title_short CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain
title_full CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain
title_fullStr CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain
title_full_unstemmed CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain
title_sort cxcr4/cxcl12 in non-small-cell lung cancer metastasis to the brain
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2013-01-01
description Lung cancer represents the leading cause of cancer-related mortality throughout the world. Patients die of local progression, disseminated disease, or both. At least one third of the people with lung cancer develop brain metastases at some point during their disease, even often before the diagnosis of lung cancer is made. The high rate of brain metastasis makes lung cancer the most common type of tumor to spread to the brain. It is critical to understand the biologic basis of brain metastases to develop novel diagnostic and therapeutic approaches. This review will focus on the emerging data supporting the involvement of the chemokine CXCL12 and its receptor CXCR4 in the brain metastatic evolution of non-small-cell lung cancer (NSCLC) and the pharmacological tools that may be used to interfere with this signaling axis.
topic brain metastases
chemokines
CXCL12
CXCR4
lung cancer
metastasis
url http://www.mdpi.com/1422-0067/14/1/1713
work_keys_str_mv AT sebastianocavallaro cxcr4cxcl12innonsmallcelllungcancermetastasistothebrain
_version_ 1725969714623021056